Gayle Robert Dolecek
Directeur/Bestuurslid bij Sucampo Pharma Europe Ltd.
Profiel
Gayle Robert Dolecek is currently a Director at Sucampo Pharma Europe Ltd.
and a Professor at Parenteral Drug Association.
Previously, Gayle was a Director and SVP-Research & Development at Sucampo Pharmaceuticals, Inc. from 2006 to 2011, and a Director-Compendial Operations at the Center for Drug Evaluation & Research.
Gayle received a graduate degree from the University of Hawai'i at Hilo and undergraduate and doctorate degrees from the University of Maryland.
Actieve functies van Gayle Robert Dolecek
| Bedrijven | Functie | Begin |
|---|---|---|
| Parenteral Drug Association | Corporate Officer/Principal | - |
Sucampo Pharma Europe Ltd.
 Sucampo Pharma Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Mallinckrodt Plc, Sucampo Pharma Europe Ltd. is a British company that develops therapies for gastrointestinal, circulatory, and ophthalmic diseases. The company is based in London, UK. Sucampo Pharma Europe was acquired by Sucampo Pharmaceuticals LLC, part of Mallinckrodt Plc from February 14, 2018 on September 28, 2006. | Directeur/Bestuurslid | 07-08-2008 |
Eerdere bekende functies van Gayle Robert Dolecek
| Bedrijven | Functie | Einde |
|---|---|---|
| Center for Drug Evaluation & Research | Corporate Officer/Principal | - |
| SUCAMPO PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | 15-11-2011 |
Opleiding van Gayle Robert Dolecek
| University of Hawai'i at Hilo | Graduate Degree |
| University of Maryland | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Sucampo Pharmaceuticals, Inc.
 Sucampo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the development, identification, acquisition, and delivery of innovative pharmaceutical products. The company was founded by Ryuji Ueno and Sachiko Kuno on December 5, 1996 and is headquartered in Bethesda, MD. | Health Technology |
Sucampo Pharma Europe Ltd.
Sucampo Pharma Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Mallinckrodt Plc, Sucampo Pharma Europe Ltd. is a British company that develops therapies for gastrointestinal, circulatory, and ophthalmic diseases. The company is based in London, UK. Sucampo Pharma Europe was acquired by Sucampo Pharmaceuticals LLC, part of Mallinckrodt Plc from February 14, 2018 on September 28, 2006. | Commercial Services |
| Parenteral Drug Association | |
| Center for Drug Evaluation & Research | Government |
